Direct application of non-toxic crosslinking reagents to...

A - Human Necessities – 61 – L

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61L 31/16 (2006.01) A61L 31/00 (2006.01)

Patent

CA 2677646

A method of improving the resistance of collagenous tissue subject to elevated collagenous tissue stress as a result of tissue removing surgical decompression surgery, comprising contacting at least a portion of the remaining collagenous tissue with an effective amount of a crossl inking reagent.

Procédé permettant d'améliorer la résistance d'un tissu collagène soumis à une contrainte élevée après une décompression chirurgicale par ablation de tissu, comprenant l'étape consistant à mettre au moins une partie du tissu collagène restant en contact avec une quantité efficace d'un réactif de réticulation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Direct application of non-toxic crosslinking reagents to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Direct application of non-toxic crosslinking reagents to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Direct application of non-toxic crosslinking reagents to... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1626839

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.